US Stock MarketDetailed Quotes

AQST Aquestive Therapeutics

Watchlist

4.460
+0.150+3.48%

Close Aug 23 16:00 ET

4.440
-0.020-0.45%

Post 20:01 ET

406.13MMarket Cap-12388P/E (TTM)

Aquestive Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

Total revenue

51.79%20.1M

8.25%12.05M

6.09%50.58M

23.63%13.21M

13.43%13M

-0.18%13.24M

-9.26%11.13M

-6.20%47.68M

-3.57%10.68M

-13.73%11.46M

Operating revenue

51.79%20.1M

8.25%12.05M

6.09%50.58M

23.63%13.21M

13.43%13M

-0.18%13.24M

-9.26%11.13M

-6.20%47.68M

-3.57%10.68M

-13.73%11.46M

Cost of revenue

-31.60%4.53M

-7.35%4.39M

7.45%20.83M

-11.80%4.68M

3.74%4.8M

26.23%6.62M

12.41%4.74M

29.33%19.39M

57.61%5.31M

5.11%4.63M

Gross profit

135.10%15.57M

19.81%7.66M

5.15%29.75M

58.58%8.53M

19.98%8.2M

-17.44%6.62M

-20.59%6.4M

-21.06%28.29M

-30.28%5.38M

-23.06%6.84M

Operating expense

43.25%15.52M

51.07%16.62M

-36.25%44.85M

-22.70%12.44M

-32.57%10.58M

-47.88%10.83M

-38.17%11M

-0.23%70.36M

-16.98%16.09M

-6.91%15.69M

Selling and administrative expenses

54.29%11.36M

43.38%10.69M

-39.96%31.75M

-19.15%9.55M

-40.73%7.39M

-52.78%7.36M

-42.75%7.46M

-1.11%52.88M

-21.15%11.81M

2.72%12.46M

Research and development costs

19.84%4.16M

67.24%5.93M

-25.04%13.1M

-32.49%2.89M

-1.11%3.2M

-33.19%3.47M

-25.69%3.55M

2.55%17.48M

-2.77%4.28M

-31.61%3.23M

Operating profit

101.31%55K

-94.51%-8.96M

64.10%-15.1M

63.49%-3.91M

73.15%-2.38M

67.02%-4.21M

52.71%-4.61M

-21.30%-42.07M

8.19%-10.71M

-11.11%-8.85M

Net non-operating interest income expense

-115.55%-2.8M

-129.72%-3.87M

171.77%8.86M

-87.31%-3.07M

105.48%202K

63.31%-1.3M

474.10%13.03M

43.99%-12.34M

52.55%-1.64M

44.09%-3.68M

Non-operating interest income

981.40%1.4M

-97.73%329K

16,385.86%16.32M

153.85%165K

30,180.00%1.51M

303.13%129K

--14.51M

-76.60%99K

-51.85%65K

--5K

Non-operating interest expense

193.77%4.2M

182.45%4.2M

-40.03%7.46M

89.85%3.24M

-64.43%1.31M

-60.02%1.43M

-57.29%1.49M

-44.60%12.44M

-52.52%1.7M

-44.01%3.69M

Other net income (expense)

-1.38M

-1.03M

-353K

Special income (charges)

--0

---1.38M

---1.03M

--0

---353K

--0

-Less:Other special charges

----

--1.38M

--1.03M

----

--353K

----

Income before tax

50.16%-2.75M

-259.00%-12.83M

85.99%-7.63M

35.15%-8.01M

82.65%-2.18M

66.21%-5.51M

161.03%8.07M

22.87%-54.41M

57.33%-12.35M

13.87%-12.54M

Income tax

245K

101K

-140K

284K

Net income

52.61%-2.75M

-259.00%-12.83M

85.54%-7.87M

34.33%-8.11M

83.77%-2.04M

64.47%-5.79M

161.03%8.07M

22.87%-54.41M

57.33%-12.35M

13.87%-12.54M

Net income continuous Operations

52.61%-2.75M

-259.00%-12.83M

85.54%-7.87M

34.33%-8.11M

83.77%-2.04M

64.47%-5.79M

161.03%8.07M

22.87%-54.41M

57.33%-12.35M

13.87%-12.54M

Minority interest income

Net income attributable to the parent company

52.61%-2.75M

-259.00%-12.83M

85.54%-7.87M

34.33%-8.11M

83.77%-2.04M

64.47%-5.79M

161.03%8.07M

22.87%-54.41M

57.33%-12.35M

13.87%-12.54M

Preferred stock dividends

Other preferred stock dividends

Net income attributable to common stockholders

52.61%-2.75M

-259.00%-12.83M

85.54%-7.87M

34.33%-8.11M

83.77%-2.04M

64.47%-5.79M

161.03%8.07M

22.87%-54.41M

57.33%-12.35M

13.87%-12.54M

Basic earnings per share

70.00%-0.03

-213.33%-0.17

88.39%-0.13

41.71%-0.1341

86.96%-0.03

72.22%-0.1

146.88%0.15

39.46%-1.12

68.06%-0.23

37.84%-0.23

Diluted earnings per share

70.00%-0.03

-254.55%-0.17

88.39%-0.13

41.71%-0.1341

86.96%-0.03

72.22%-0.1

134.38%0.11

39.46%-1.12

68.06%-0.23

37.84%-0.23

Dividend per share

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022
Total revenue	51.79%20.1M	8.25%12.05M	6.09%50.58M	23.63%13.21M	13.43%13M	-0.18%13.24M	-9.26%11.13M	-6.20%47.68M	-3.57%10.68M	-13.73%11.46M
Operating revenue	51.79%20.1M	8.25%12.05M	6.09%50.58M	23.63%13.21M	13.43%13M	-0.18%13.24M	-9.26%11.13M	-6.20%47.68M	-3.57%10.68M	-13.73%11.46M
Cost of revenue	-31.60%4.53M	-7.35%4.39M	7.45%20.83M	-11.80%4.68M	3.74%4.8M	26.23%6.62M	12.41%4.74M	29.33%19.39M	57.61%5.31M	5.11%4.63M
Gross profit	135.10%15.57M	19.81%7.66M	5.15%29.75M	58.58%8.53M	19.98%8.2M	-17.44%6.62M	-20.59%6.4M	-21.06%28.29M	-30.28%5.38M	-23.06%6.84M
Operating expense	43.25%15.52M	51.07%16.62M	-36.25%44.85M	-22.70%12.44M	-32.57%10.58M	-47.88%10.83M	-38.17%11M	-0.23%70.36M	-16.98%16.09M	-6.91%15.69M
Selling and administrative expenses	54.29%11.36M	43.38%10.69M	-39.96%31.75M	-19.15%9.55M	-40.73%7.39M	-52.78%7.36M	-42.75%7.46M	-1.11%52.88M	-21.15%11.81M	2.72%12.46M
Research and development costs	19.84%4.16M	67.24%5.93M	-25.04%13.1M	-32.49%2.89M	-1.11%3.2M	-33.19%3.47M	-25.69%3.55M	2.55%17.48M	-2.77%4.28M	-31.61%3.23M
Operating profit	101.31%55K	-94.51%-8.96M	64.10%-15.1M	63.49%-3.91M	73.15%-2.38M	67.02%-4.21M	52.71%-4.61M	-21.30%-42.07M	8.19%-10.71M	-11.11%-8.85M
Net non-operating interest income expense	-115.55%-2.8M	-129.72%-3.87M	171.77%8.86M	-87.31%-3.07M	105.48%202K	63.31%-1.3M	474.10%13.03M	43.99%-12.34M	52.55%-1.64M	44.09%-3.68M
Non-operating interest income	981.40%1.4M	-97.73%329K	16,385.86%16.32M	153.85%165K	30,180.00%1.51M	303.13%129K	--14.51M	-76.60%99K	-51.85%65K	--5K
Non-operating interest expense	193.77%4.2M	182.45%4.2M	-40.03%7.46M	89.85%3.24M	-64.43%1.31M	-60.02%1.43M	-57.29%1.49M	-44.60%12.44M	-52.52%1.7M	-44.01%3.69M
Other net income (expense)			-1.38M	-1.03M			-353K
Special income (charges)	--0	--0	---1.38M	---1.03M	--0	--0	---353K	--0	--0	--0
-Less:Other special charges	----	----	--1.38M	--1.03M	----	----	--353K	----	----	----
Income before tax	50.16%-2.75M	-259.00%-12.83M	85.99%-7.63M	35.15%-8.01M	82.65%-2.18M	66.21%-5.51M	161.03%8.07M	22.87%-54.41M	57.33%-12.35M	13.87%-12.54M
Income tax	0	0	245K	101K	-140K	284K	0	0	0	0
Net income	52.61%-2.75M	-259.00%-12.83M	85.54%-7.87M	34.33%-8.11M	83.77%-2.04M	64.47%-5.79M	161.03%8.07M	22.87%-54.41M	57.33%-12.35M	13.87%-12.54M
Net income continuous Operations	52.61%-2.75M	-259.00%-12.83M	85.54%-7.87M	34.33%-8.11M	83.77%-2.04M	64.47%-5.79M	161.03%8.07M	22.87%-54.41M	57.33%-12.35M	13.87%-12.54M
Minority interest income
Net income attributable to the parent company	52.61%-2.75M	-259.00%-12.83M	85.54%-7.87M	34.33%-8.11M	83.77%-2.04M	64.47%-5.79M	161.03%8.07M	22.87%-54.41M	57.33%-12.35M	13.87%-12.54M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders	52.61%-2.75M	-259.00%-12.83M	85.54%-7.87M	34.33%-8.11M	83.77%-2.04M	64.47%-5.79M	161.03%8.07M	22.87%-54.41M	57.33%-12.35M	13.87%-12.54M
Basic earnings per share	70.00%-0.03	-213.33%-0.17	88.39%-0.13	41.71%-0.1341	86.96%-0.03	72.22%-0.1	146.88%0.15	39.46%-1.12	68.06%-0.23	37.84%-0.23
Diluted earnings per share	70.00%-0.03	-254.55%-0.17	88.39%-0.13	41.71%-0.1341	86.96%-0.03	72.22%-0.1	134.38%0.11	39.46%-1.12	68.06%-0.23	37.84%-0.23
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall